- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Proteolysis targeting chimeras (PROTACs) in cancer therapy ; volume:39 ; number:1 ; day:15 ; month:9 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (15.9.2020), 1-9, 12.2020
- Creator
-
Ocaña, Alberto
Pandiella, Atanasio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-01672-1
- URN
-
urn:nbn:de:101:1-2020110319595840552076
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ocaña, Alberto
- Pandiella, Atanasio
- SpringerLink (Online service)
Other Objects (12)
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity
Interleukin-6-interleukin-11 receptor chimeras reveal ionomycin-induced proteolysis beyond ADAM10
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras“ (PROTACs): Synthese und biologische Testung
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Biological Assessment and Tests of Activity of Two Novel Proteolysis Targeting Chimeras (PROTACs)
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity